Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT00135356
Eligibility Criteria:
Inclusion Criteria:
* HIV-1 infected on HAART regimen containing 2 NRTI and boosted PI for at least 12 weeks prior to screening. Subjects may not have experienced virological failure to more than one prior PI-containing regimen. Must be able to swallow tablets
* Viral load \<400 c/mL at screening and stable for at least 6 months
* Signs of fat redistribution and lipohypertrophy (abdominal) Waist to Hip Ratio \>0.90 and Waist Circumference \>88.2 cm for men and Waist Circumference \>75.3 for women
Exclusion Criteria:
* Pregnant or breastfeeding women
* New HIV-related opportunistic infections
* Active alcohol or substance use
* Grade 4 lab toxicity
* History of taking atazanavir (ATV)
* Prohibited therapies, including non-nucleoside reverse transcriptase inhibitors (NNRTI)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00135356
Study Brief:
Protocol Section:
NCT00135356